Business Standard

Sun Pharma surges 4%, hits 52-week high; stock rallies 76% from March-low

For the quarter ended June 2020, Sun Pharma reported a surprise loss due to one-time charges.

Sebi starts probe against Sun Pharma, to also reopen insider trading case
Premium

The company’s US business posted a 33.5 per cent decline during June 2020 quarter.

SI Reporter New Delhi
Shares of Sun Pharmaceutical Industries surged around 4 per cent to hit a fresh 52-week high of Rs 554.90 on the BSE on Friday. With today's rally, the stock has climbed 76 per cent from its 52-week low of Rs 315.20, hit on March 23, 2020. 

At 01: 48 pm, the stock was trading 3.5 per cent higher at Rs 551.55. In comparison, the S&P BSE Sensex was trading nearly 1 per cent higher at 39,465 levels. 

For the quarter ended June 2020, Sun Pharma registered a surprise loss due to one-time charges. The company’s US business posted a 33.5 per cent

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in